Yıl: 2023 Cilt: 33 Sayı: 1 Sayfa Aralığı: 85 - 93 Metin Dili: İngilizce DOI: 10.4274/terh.galenos.2022.82997 İndeks Tarihi: 05-05-2023

Extensive Peritoneal Lavage (EIPL) with Saline After Curative D2 Gastric Resection For Treatment of Locally Advanced Gastric Cancer Patients

Öz:
Objective: This study evaluated extensive intraoperative peritoneal lavage (EIPL) on overall survival (OS), adverse events, and recurrence type in gastric cancer patients who underwent curative D2 lymph node dissection. Methods: Medical records of 235 patients undergoing D2 curative gastrectomy for clinically locally advanced gastric cancer without peritoneal carcinomatosis between January 2011 and October 2021 were reviewed retrospectively. Patients were grouped according to surgery plus EIPL and non-EIPL. Clinicopathological features and recurrence type, prognostic factors on OS, and incidence of adverse events were evaluated. Results: The mean age of patients included in this study was 63 years in the EIPL group and 61 in the non-EIPL group. The OS rate of patients with EIPL was 63%, and the non-EIPL group was 61.6%. All postoperative complications were less in the EIPL group (p=0.008). Peritoneal metastases were less in the EIPL group (p=0.003). Conclusion: Free cancer cells in the abdominal cavity may be detected due of tumor manipulation and lymphovascular dissection during surgery. Using EIPL can reduce peritoneal recurrence. Postoperative complications due to exudate, debris, and possible intestinal content caused by perioperative dissection can be prevented with EIPL.
Anahtar Kelime:

Lokal İleri Mide Kanseri Hastalarının Tedavisinde Küratif D2 Rezeksiyonu Sonrası İzotonik Sıvı ile Extensive Peritoneal Lavage (EIPL)

Öz:
Amaç: Bu çalışmanın amacı, küratif D2 lenf nodu diseksiyonu uygulanan mide kanseri hastalarında ekstensiv intraoperative peritoneal lavaj (EIPL) yapılmasının sağkalım, nüks tipi ve postoperatif komplikasyonlar üzerindeki etkisini araştırmaktır. Yöntem: Ocak 2011 ile Ekim 2021 arasında klinik olarak lokal ileri mide kanseri nedeniyle küratif gastrektomi ve D2 lenf nodu diseksiyonu uygulanan periton metastazı olmayan 235 hastanın kayıtları geriye dönük olarak incelendi. Cerrahi sonrası EIPL yapılan ve yapılmayan hastalar değerlendirildi. Genel sağkalım (OS), nüks tipi, klinikopatolojik özellikler ve postoperative komplikasyonlar değerlendirildi. EIPL yapılan ve EIPL yapılmayan (non-EIPL) hasta grupları karşılaştırıldı. Bulgular: Çalışmaya dahil edilen hastaların ortalama yaşı non-EIPL grubunda 61, EIPL grubunda 63 idi. OS oranı EIPL grubunda %63, non-EIPL grubunda ise %61,6 idi. Tüm postoperatif komplikasyonlar EIPL grubunda daha azdı (p=0,008). Peritoneal metastaz EIPL grubunda daha azdı (p=0,003). Sonuç: Cerrahi rezeksiyon sırasında tümör manipülasyonu ve lenfovasküler diseksiyona bağlı intraabdominal kavitede serbest kanser hücreleri görülebilir. EIPL uygulanması ile iatrojenik serbest kanser hücreleri peritoneal implantasyonu gelişmesi azaltılabilir. Peroperatif diseksiyona bağlı periton içerisine dökülen debrislerin, eksudanın ve muhtemel barsak içeriğinin EIPL ile yok edilmesiyle postoperatif komplikasyonlar azaltılabilir.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394- 424.
  • 2. Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2018 (5th edition). Gastric Cancer 2021;24:1-21.
  • 3. Smyth EC, Verheij M, Allum W, Cunningham D, Cervantes A, Arnold D; ESMO Guidelines Committee. Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2016;27:38-9.
  • 4. Wei J, Wu ND, Liu BR. Regional but fatal: Intraperitoneal metastasis in gastric cancer. World J Gastroenterol 2016;22:7478-85.
  • 5. Dahdaleh FS, Turaga KK. Evolving Treatment Strategies and Outcomes in Advanced Gastric Cancer with Peritoneal Metastasis. Surg Oncol Clin N Am 2018;27:519-37.
  • 6. Amin MB, Greene FL, Edge SB, et al. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging. CA Cancer J Clin 2017;67:93-9.
  • 7. Ji ZH, Zhang Y, Li Y. Intra-operative hyperthermic intraperitoneal chemotherapy for prevention and treatment of peritoneal metastases from gastric cancer: a narrative review. J Gastrointest Oncol 2021;12:70- 8.
  • 8. Arita T, Ichikawa D, Konishi H, et al. Increase in peritoneal recurrence induced by intraoperative hemorrhage in gastrectomy. Ann Surg Oncol 2015;22:758-64.
  • 9. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature 2008 24;454:436-44.
  • 10. Kanda M, Kodera Y. Molecular mechanisms of peritoneal dissemination in gastric cancer. World J Gastroenterol 2016;22:6829-40.
  • 11. Marutsuka T, Shimada S, Shiomori K, et al. Mechanisms of peritoneal metastasis after operation for non-serosa-invasive gastric carcinoma: an ultrarapid detection system for intraperitoneal free cancer cells and a prophylactic strategy for peritoneal metastasis. Clin Cancer Res 2003;9:678-85.
  • 12. Shimada S, Tanaka E, Marutsuka T, et al. Extensive intraoperative peritoneal lavage and chemotherapy for gastric cancer patients with peritoneal free cancer cells. Gastric Cancer 2002;5:168-72.
  • 13. Kuramoto M, Shimada S, Ikeshima S, et al. Extensive intraoperative peritoneal lavage as a standard prophylactic strategy for peritoneal recurrence in patients with gastric carcinoma. Ann Surg 2009;250:242-6.
  • 14. Shimada S, Kuramoto M, Marutsuka T, Yagi Y, Baba H. Adopting extensive intra-operative peritoneal lavage (EIPL) as the standard prophylactic strategy for peritoneal recurrence. Rev Recent Clin Trials 2011;6:266-70.
  • 15. Kuramoto M, Shimada S, Ikeshima S, et al. A proposal of a practical and optimal prophylactic strategy for peritoneal recurrence. J Oncol 2012;2012:340380.
  • 16. Misawa K, Mochizuki Y, Sakai M, et al. Randomized clinical trial of extensive intraoperative peritoneal lavage versus standard treatment for resectable advanced gastric cancer (CCOG 1102 trial). Br J Surg 2019;106:1602-10.
  • 17. Guo J, Xu A, Sun X, et al. Combined Surgery and Extensive Intraoperative Peritoneal Lavage vs Surgery Alone for Treatment of Locally Advanced Gastric Cancer: The SEIPLUS Randomized Clinical Trial. JAMA Surg 2019;154:610-16.
  • 18. Yang HK, Ji J, Han SU, et al. EXPEL study group. Extensive peritoneal lavage with saline after curative gastrectomy for gastric cancer (EXPEL): a multicentre randomised controlled trial. Lancet Gastroenterol Hepatol 2021;6:120-7.
  • 19. Virgilio E, Giarnieri E, Giovagnoli MR, et al. Gastric Cancer Cells in Peritoneal Lavage Fluid: A Systematic Review Comparing Cytological with Molecular Detection for Diagnosis of Peritoneal Metastases and Prediction of Peritoneal Recurrences. Anticancer Res 2018;38:1255-62.
  • 20. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004;240:205-13.
  • 21. Glehen O, Passot G, Villeneuve L, et al. GASTRICHIP: D2 resection and hyperthermic intraperitoneal chemotherapy in locally advanced gastric carcinoma: a randomized and multicenter phase III study. BMC Cancer 2014;14:183.
  • 22. Coccolini F, Fugazzola P, Ansaloni L, et al. Advanced gastric cancer: the value of systemic and intraperitoneal chemotherapy. Acta Biomed 2018;89:104-9.
  • 23. Ceelen W, Braet H, van Ramshorst G, Willaert W, Remaut K. Intraperitoneal chemotherapy for peritoneal metastases: an expert opinion. Expert Opin Drug Deliv 2020;17:511-22.
  • 24. Leake PA, Cardoso R, Seevaratnam R, et al. A systematic review of the accuracy and utility of peritoneal cytology in patients with gastric cancer. Gastric Cancer 2012;15:S27-7.
  • 25. Ronellenfitsch U, Ernst K, Mertens C, et al. Extensive intraperitoneal lavage to eliminate intraperitoneal tumor cells in gastrectomy with D2 lymphadenectomy for gastric cancer. Tumori 2018;104:361-8.
  • 26. Masuda T, Kuramoto M, Shimada S, et al. The effect of extensive intraoperative peritoneal lavage therapy (EIPL) on stage III B + C and cytology-positive gastric cancer patients. Int J Clin Oncol 2016;21:289-4.
  • 27. Batista TP, Martins MR, Martins-Filho ED, Santos RL. A PHASE II TRIAL EXPLORING THE EXTENSIVE INTRA-OPERATIVE PERITONEAL LAVAGE (EIPL) AS A PROPHYLACTIC STRATEGY FOR PERITONEAL RECURRENCE IN LOCALLY ADVANCED GASTRIC CANCER: reporting postoperative morbidity and mortality after early closure. Arq Gastroenterol 2015;52:161-4.
  • 28. Rodríguez-Santiago J, Luna A, Garsot E, Aldeano A, Balagué C, Rada A. Extended intraoperative peritoneal lavage as prophylactic peritoneal recurrence for locally advanced gastric cancer: a prospective randomized trial. Clin Transl Oncol 2021;23:1857-65.
  • 29. Ruiz-Tovar J, Llavero C, Muñoz JL, Zubiaga L, Diez M. Effect of Peritoneal Lavage with Clindamycin-Gentamicin Solution on Post-Operative Pain and Analytic Acute-Phase Reactants after Laparoscopic Sleeve Gastrectomy. Surg Infect (Larchmt) 2016;17:357-62.
  • 30. Han TS, Kong SH, Lee HJ, et al. Dissemination of free cancer cells from the gastric lumen and from perigastric lymphovascular pedicles during radical gastric cancer surgery. Ann Surg Oncol 2011;18:2818-25.
  • 31. Yamamoto K, Shimada S, Hirota M, Yagi Y, Matsuda M, Baba H. EIPL (extensive intraoperative peritoneal lavage) therapy significantly reduces peritoneal recurrence after pancreatectomy in patients with pancreatic cancer. Int J Oncol 2005;27:1321-8.
APA alemdar a, duman m, şengiz erhan s, GUNER A, Yılmaz İ (2023). Extensive Peritoneal Lavage (EIPL) with Saline After Curative D2 Gastric Resection For Treatment of Locally Advanced Gastric Cancer Patients. , 85 - 93. 10.4274/terh.galenos.2022.82997
Chicago alemdar ali,duman mehmet güray,şengiz erhan selma,GUNER Ali,Yılmaz İsmayil Extensive Peritoneal Lavage (EIPL) with Saline After Curative D2 Gastric Resection For Treatment of Locally Advanced Gastric Cancer Patients. (2023): 85 - 93. 10.4274/terh.galenos.2022.82997
MLA alemdar ali,duman mehmet güray,şengiz erhan selma,GUNER Ali,Yılmaz İsmayil Extensive Peritoneal Lavage (EIPL) with Saline After Curative D2 Gastric Resection For Treatment of Locally Advanced Gastric Cancer Patients. , 2023, ss.85 - 93. 10.4274/terh.galenos.2022.82997
AMA alemdar a,duman m,şengiz erhan s,GUNER A,Yılmaz İ Extensive Peritoneal Lavage (EIPL) with Saline After Curative D2 Gastric Resection For Treatment of Locally Advanced Gastric Cancer Patients. . 2023; 85 - 93. 10.4274/terh.galenos.2022.82997
Vancouver alemdar a,duman m,şengiz erhan s,GUNER A,Yılmaz İ Extensive Peritoneal Lavage (EIPL) with Saline After Curative D2 Gastric Resection For Treatment of Locally Advanced Gastric Cancer Patients. . 2023; 85 - 93. 10.4274/terh.galenos.2022.82997
IEEE alemdar a,duman m,şengiz erhan s,GUNER A,Yılmaz İ "Extensive Peritoneal Lavage (EIPL) with Saline After Curative D2 Gastric Resection For Treatment of Locally Advanced Gastric Cancer Patients." , ss.85 - 93, 2023. 10.4274/terh.galenos.2022.82997
ISNAD alemdar, ali vd. "Extensive Peritoneal Lavage (EIPL) with Saline After Curative D2 Gastric Resection For Treatment of Locally Advanced Gastric Cancer Patients". (2023), 85-93. https://doi.org/10.4274/terh.galenos.2022.82997
APA alemdar a, duman m, şengiz erhan s, GUNER A, Yılmaz İ (2023). Extensive Peritoneal Lavage (EIPL) with Saline After Curative D2 Gastric Resection For Treatment of Locally Advanced Gastric Cancer Patients. İzmir Tepecik Eğitim Hastanesi Dergisi, 33(1), 85 - 93. 10.4274/terh.galenos.2022.82997
Chicago alemdar ali,duman mehmet güray,şengiz erhan selma,GUNER Ali,Yılmaz İsmayil Extensive Peritoneal Lavage (EIPL) with Saline After Curative D2 Gastric Resection For Treatment of Locally Advanced Gastric Cancer Patients. İzmir Tepecik Eğitim Hastanesi Dergisi 33, no.1 (2023): 85 - 93. 10.4274/terh.galenos.2022.82997
MLA alemdar ali,duman mehmet güray,şengiz erhan selma,GUNER Ali,Yılmaz İsmayil Extensive Peritoneal Lavage (EIPL) with Saline After Curative D2 Gastric Resection For Treatment of Locally Advanced Gastric Cancer Patients. İzmir Tepecik Eğitim Hastanesi Dergisi, vol.33, no.1, 2023, ss.85 - 93. 10.4274/terh.galenos.2022.82997
AMA alemdar a,duman m,şengiz erhan s,GUNER A,Yılmaz İ Extensive Peritoneal Lavage (EIPL) with Saline After Curative D2 Gastric Resection For Treatment of Locally Advanced Gastric Cancer Patients. İzmir Tepecik Eğitim Hastanesi Dergisi. 2023; 33(1): 85 - 93. 10.4274/terh.galenos.2022.82997
Vancouver alemdar a,duman m,şengiz erhan s,GUNER A,Yılmaz İ Extensive Peritoneal Lavage (EIPL) with Saline After Curative D2 Gastric Resection For Treatment of Locally Advanced Gastric Cancer Patients. İzmir Tepecik Eğitim Hastanesi Dergisi. 2023; 33(1): 85 - 93. 10.4274/terh.galenos.2022.82997
IEEE alemdar a,duman m,şengiz erhan s,GUNER A,Yılmaz İ "Extensive Peritoneal Lavage (EIPL) with Saline After Curative D2 Gastric Resection For Treatment of Locally Advanced Gastric Cancer Patients." İzmir Tepecik Eğitim Hastanesi Dergisi, 33, ss.85 - 93, 2023. 10.4274/terh.galenos.2022.82997
ISNAD alemdar, ali vd. "Extensive Peritoneal Lavage (EIPL) with Saline After Curative D2 Gastric Resection For Treatment of Locally Advanced Gastric Cancer Patients". İzmir Tepecik Eğitim Hastanesi Dergisi 33/1 (2023), 85-93. https://doi.org/10.4274/terh.galenos.2022.82997